newsfilter
← Latest News
FDA Approved Drugs·

Approval of Zyban, Nda #020711 (Labeling)

Approval Date: 07/13/2026; Drug Name: Zyban, Nda #020711; Active Ingredients: BUPROPION HYDROCHLORIDE; Company: Glaxosmithkline; Submission Status: Approval; Submission Classification: Labeling; Application Number: 020711

Company
GLAXOSMITHKLINE
Keywords
GLAXOSMITHKLINE